News for OncoSec Medical Incorporated (ONCS)

The triple-negative breast cancer market is witnessing significant growth and evolution due to increased awareness, technological advancements, therapeutic...

The dynamics of the intratumoral cancer therapies market are anticipated to change in the coming years owing to the approval of several drugs targeting...

NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of Puhui Wealth Investment...

U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500, also rose, gaining, 1.31% to 4,429.89.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT ... | June 14, 2023

Oncosec Medical CFO Terminated for Cause

/PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral...

Oncosec Medical Announces 1.41M Share Offering at $0.945/sh

EWING, N.J. and SAN DIEGO, May 16, 2023 /PRNewswire/ -- OncoSec Medical Incorporated , a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's... | May 16, 2023

Oncosec Medical Announces Type C Meeting with FDA

The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.05 A.M. ET)..

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 200 points on Wednesday.

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.40 A.M. ET)..

HER2 negative Breast Cancer Pipeline involves 85+ key companies continuously working towards developing 85+ HER2 negative Breast Cancer treatment...

While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending,...

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter,...

Check out Top Biotech Stocks to Watch for February 2021 by Bohen's team at StocksToTrade. Read more and learn now!

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 1) Abbott ...